相关实验视频
Updated: Jun 5, 2025

06:51
A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
5.3K
针对血管异常的有针对性的医学疗法
1Comprehensive Vascular Anomalies Program, The Children's Hospital of Philadelphia, Philadelphia, PA.
Hematology. American Society of Hematology. Education Program
|December 7, 2024
概括
最近的遗传发现显示,许多血管异常源于特定的基因突变. 这导致了向治疗,并扩大了血液学家/瘤学家在治疗这些疾病方面的作用.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 血管生物学 血管生物学
背景情况:
- 在过去的20年中,遗传学的发现显著提高了对血管异常的理解.
- 许多血管异常现在被理解为主要细胞内信号通路中的体质功能增益变体所驱动.
研究的目的:
- 突出基因发现对血管异常治疗的影响.
- 强调血液学家/瘤学家在管理这些疾病方面的不断变化的作用.
- 强调了解针对血管异常的向治疗的重要性.
主要方法:
- 关于血管异常的最新遗传发现的审查.
- 在血管异常中涉及的关键细胞内信号通路的识别 (PI3K/AKT/mTOR和Ras/MAPK).
- 针对性抗血管原剂的引入和应用的分析.
主要成果:
- 针对性的医学疗法现在是管理患有血管异常的患者的核心.
- 在PI3K/AKT/mTOR和Ras/MAPK通路中的体质功能增益变异是血管异常的常见驱动因素.
- 已经引入了抑制这些通路的抗血管原剂.
结论:
- 基因洞察力已经彻底改变了血管异常治疗,使得有针对性的治疗成为可能.
- 血液学家/瘤学家在护理患有血管异常的患者中发挥着越来越重要的作用.
- 血液学家/瘤学家对这些向药物的指示和安全使用进行培训是必不可少的.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
Overview of the Vascular System
2.7K
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
2.7K

